GleamWall
中文EN

Elmind Capital, LP

NEW YORK NY · SEC CIK 0002052213

2026Q22026Q1 9 earlier quarters 🔒
$398.03M2026Q2 reported value
35Positions
66.6%Top 10 weight · largest 11.4%
5 / 4New / sold out
Reported value over time$398.03M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

COGT 11.4%
SNDX 10.2%
CLDX 9.3%
RLAY 6.9%
PCVX 6.6%
VERA 4.7%
PHVS 4.6%
VRDN 4.5%
CTMX 4.3%
TVTX 4.2%

2026Q2 top buys estimated at quarter-end value

RLAY Added+$17.37M
LEGN New+$16.48M
VRDN Added+$8.27M
PCVX Added+$7.90M
SMMT New+$7.19M

2026Q2 top sells estimated at quarter-end value

KALVISTA PHARMAC Sold out-$20.56M
CGON Sold out-$19.75M
TYRA Reduced-$10.54M
MBX Reduced-$6.62M
BCRX Reduced-$4.80M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
COGT COGENT BIOSCIENCES INC $45.31M11.38%1,170,740 00.0% — Unchanged
SNDX SYNDAX PHARMACEUTICALS INC $40.55M10.19%1,855,000 00.0% — Unchanged
CLDX CELLDEX THERAPEUTICS INC NEW $36.84M9.25%990,000 125,00014.5% $4.65M Added
RLAY RELAY THERAPEUTICS INC $27.42M6.89%1,465,279 928,333172.9% $17.37M Added
PCVX VAXCYTE INC $26.29M6.61%452,340 135,84042.9% $7.90M Added
VERA VERA THERAPEUTICS INC $18.73M4.71%436,518 -45,982-9.5% -$1.97M Reduced
PHVS PHARVARIS N V $18.18M4.57%525,750 50,00010.5% $1.73M Added
VRDN VIRIDIAN THERAPEUTICS INC $18.09M4.55%984,931 450,00084.1% $8.27M Added
CTMX CYTOMX THERAPEUTICS INC. $17.06M4.29%4,550,000 00.0% — Unchanged
TVTX TRAVERE THERAPEUTICS INC $16.62M4.18%292,600 115,00064.8% $6.53M Added
LEGN LEGEND BIOTECH CORP $16.48M4.14%570,569 570,569— $16.48M New
BEAM BEAM THERAPEUTICS INC $16.35M4.11%476,338 00.0% — Unchanged
CGEM CULLINAN THERAPEUTICS INC $12.56M3.16%690,000 160,00030.2% $2.91M Added
NRIX NURIX THERAPEUTICS INC $11.16M2.80%460,000 00.0% — Unchanged
KRYS KRYSTAL BIOTECH INC $8.18M2.05%22,000 00.0% — Unchanged
UTHR UNITED THERAPEUTICS CORP DEL $8.13M2.04%15,000 00.0% — Unchanged
SMMT SUMMIT THERAPEUTICS INC $7.19M1.81%493,820 493,820— $7.19M New
INSM INSMED INC $6.93M1.74%65,000 65,000— $6.93M New
BCRX BIOCRYST PHARMACEUTICALS INC $5.20M1.31%520,000 -480,000-48.0% -$4.80M Reduced
MBX MBX BIOSCIENCES INC $5.02M1.26%91,000 -120,000-56.9% -$6.62M Reduced
PTGX PROTAGONIST THERAPEUTICS INC $4.66M1.17%38,000 00.0% — Unchanged
URGN UROGEN PHARMA LTD $4.42M1.11%120,000 -100,000-45.5% -$3.68M Reduced
DBVT DBV TECHNOLOGIES S A $4.35M1.09%265,000 00.0% — Unchanged
ALMS ALUMIS INC $3.66M0.92%130,000 00.0% — Unchanged
— SUPERNUS PHARMACEUTICALS $3.26M0.82%70,000 50,000250.0% $2.33M Added
BMRN BIOMARIN PHARMACEUTICAL INC $2.69M0.68%47,000 00.0% — Unchanged
IMCR IMMUNOCORE HLDGS PLC $2.58M0.65%81,143 22,89539.3% $726,916 Added
AMLX AMYLYX PHARMACEUTICALS INC $2.01M0.51%112,000 00.0% — Unchanged
ALEC ALECTOR INC $1.81M0.45%900,000 00.0% — Unchanged
SEPN SEPTERNA INC $1.66M0.42%49,444 49,444— $1.66M New
DSGN DESIGN THERAPEUTICS INC $1.56M0.39%107,900 -100,000-48.1% -$1.45M Reduced
STRO SUTRO BIOPHARMA INC $1.06M0.27%32,037 32,037— $1.06M New
WVE WAVE LIFE SCIENCES LTD $1.03M0.26%177,846 00.0% — Unchanged
TYRA TYRA BIOSCIENCES INC $638,8000.16%20,000 -330,000-94.3% -$10.54M Reduced
— ENGENE THERAPEUTICS INC $363,3000.09%210,000 00.0% — Unchanged
— KALVISTA PHARMACEUTICALS INC $00.00%0 -1,021,300-100.0% -$20.56M Sold out
CGON CG ONCOLOGY INC $00.00%0 -291,800-100.0% -$19.75M Sold out
— APELLIS PHARMACEUTICALS INC $00.00%0 -50,000-100.0% -$2.01M Sold out
EWTX EDGEWISE THERAPEUTICS INC $00.00%0 -10,000-100.0% -$315,000 Sold out